NCT01847898 is a Phase 4 clinical trial of Vertebral Body Stenting (VBS) in Vertebral Body Fractures, sponsored by Synthes GmbH.

Who is sponsoring NCT01847898?

NCT01847898 is sponsored by Synthes GmbH.

What drugs are being tested in NCT01847898?

Interventions in NCT01847898: Vertebral Body Stenting (VBS), Balloon Kyphoplasty.

What condition does NCT01847898 study?

NCT01847898 studies Vertebral Body Fractures.

Is NCT01847898 still recruiting?

NCT01847898 is currently completed. Last updated 14 March 2017.

Last reviewed 2017-03-14 · How we verify

NCT01847898

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study on the Treatment of Osteoporotic Vertebral Fractures Using Vertebral Body Stenting

Completed Phase 4 Last updated 14 March 2017

What this trial tests

Phase 4 trial testing Vertebral Body Stenting (VBS) in Vertebral Body Fractures in 100 participants. Completed in 31 December 2015.

Timeline

1 September 2009

Primary endpoint
31 December 2015

31 December 2015

Quick facts

Lead sponsor	Synthes GmbH
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 September 2009
Primary completion	31 December 2015
Estimated completion	31 December 2015
Sites	5 locations across Austria, Germany

Drugs / interventions tested

Vertebral Body Stenting (VBS)
Balloon Kyphoplasty

Conditions studied

Vertebral Body Fractures — all drugs for Vertebral Body Fractures →

Sponsor

Synthes GmbH

Who can join

50 and older, any sex, with Vertebral Body Fractures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, controlled study to document and evaluate the clinical performance of the Vertebral Body Stenting (VBS) System in osteoporotic fractures of the thoracic and lumbar spine. The randomized, controlled trial (RCT) will compare patients with VBS and Balloon Kyphoplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Synthes GmbH trials

Trials by the same sponsor.

NCT03635320 — The CHINA TFNA Study · NA · completed
NCT02203448 — Facet Wedge Post Market Study · completed
NCT02056834 — chronOS Inject in Proximal Tibial Fractures · completed
NCT01048710 — Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01847898 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Synthes GmbH
Last refreshed: 14 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01847898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing